Emerson Electric
EMR
$157.26
+1.64%
Emerson Electric Co. is a global industrial automation leader that designs and manufactures a wide range of automation software, valves, gauges, switches, and power tools, serving industries such as process manufacturing, energy, and discrete manufacturing. The company has transformed itself into a pure-play automation player through strategic divestitures of its climate technology and consumer businesses, positioning it as a key beneficiary of the long-term trend toward factory automation and digital transformation. Currently, investor attention is focused on Emerson's ability to sustain growth amid global industrial cycles, its margin expansion initiatives, and the integration of recent acquisitions to enhance its software and systems offerings. The stock has shown strong momentum in 2026, reflecting optimism about the company's strategic direction and operational execution.…
EMR
Emerson Electric
$157.26
Investment Opinion: Should I buy EMR Today?
Rating: Buy. Emerson Electric is a high-quality industrial automation company with a clear strategic direction and strong execution. The consensus rating is 'Buy' with an average target price of $171.07, implying an 8.8% upside. The thesis is supported by margin expansion, a growing software business, and a solid balance sheet.
Sign up to view all
EMR 12-Month Price Forecast
The AI assessment leans bullish, driven by Emerson's strategic focus on automation, solid margins, and positive analyst sentiment. However, the medium confidence reflects the modest growth and valuation concerns. The stance would be upgraded to high confidence if revenue growth accelerates above 5% or if the stock pulls back to a more attractive valuation. Conversely, it would be downgraded if revenue growth stalls or if the stock fails to hold its current support levels.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Emerson Electric's 12-month outlook, with a consensus price target around $171.44 and implied upside of +9.0% versus the current price.
Average Target
$171.44
0 analysts
Implied Upside
+9.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$104 - $205
Analyst target range
Emerson is covered by 27 analysts, with a consensus recommendation of 'Buy' and a mean recommendation score of 1.93 (where 1 is Strong Buy and 5 is Sell). The average target price is $171.07, implying an upside of approximately 8.8% from the current price of $157.26. The distribution of ratings is not provided, but the mean score suggests a bullish tilt, with many analysts likely rating it as Buy or Outperform. The high target of $205.00 implies a 30.4% upside, while the low target of $104.00 implies a -33.9% downside, indicating a wide range of expectations and significant uncertainty about the stock's future performance.
Drowning in data?
Find the real signal!
Bulls vs Bears: EMR Investment Factors
Emerson Electric presents a balanced investment case. On the bull side, the company's strategic pivot to pure-play automation, solid margin expansion, and strong analyst support provide a compelling narrative. On the bear side, modest revenue growth, elevated valuation multiples, and potential overbought conditions temper enthusiasm. Currently, the bull case has slightly stronger evidence, given the company's clear strategic direction and improving profitability. The most critical tension is whether Emerson can accelerate revenue growth beyond low-single digits to justify its premium valuation. If growth remains tepid, the stock could face de-rating; if it accelerates, the stock has room to run toward the high target.
Bullish
- Pure-play automation leader: Emerson has divested climate and consumer businesses to become a pure-play industrial automation company, aligning with the secular trend of factory automation. This strategic focus enhances its growth profile and makes it a direct beneficiary of digital transformation in manufacturing.
- Strong margin expansion: Gross margin improved to 53.1% in Q2 FY2026 from 53.5% a year ago, while operating margin rose to 19.8% from 19.4%. This demonstrates successful cost management and a shift toward higher-margin software and systems, which now contribute 33% of revenue.
- Analyst consensus is Buy: With 27 analysts, the mean recommendation is 1.93 (between Buy and Strong Buy), and the average target price of $171.07 implies an 8.8% upside from the current price of $157.26. This reflects broad confidence in the company's strategy and execution.
- Healthy free cash flow: Free cash flow (TTM) stands at $3.115 billion, supporting a dividend yield of 1.61% and a payout ratio of 52%. This provides a solid foundation for shareholder returns and balance sheet strength.
Bearish
- Modest revenue growth: Revenue grew only 2.9% YoY in Q2 FY2026 to $4.562 billion, and the prior quarter grew just 4.1%. This low-single-digit growth is typical of a mature industrial company and may not justify a premium valuation.
- Elevated valuation multiples: The trailing PE is 32.2x and the forward PE is 21.7x, both above the historical average for industrial companies. The PEG ratio of 1.78 suggests the stock is not cheap relative to its expected growth, leaving limited margin of safety.
- High short interest: The short ratio is 4.81, indicating a significant number of shares sold short. This suggests that some investors are betting against the stock, potentially due to concerns about cyclicality or valuation.
- Potential overbought conditions: The stock is trading at 94.5% of its 52-week range, and the 6-month price change of +5.8% lags the 1-year change of +20.9%. This suggests the recent rally may be overextended, increasing the risk of a pullback.
EMR Technical Analysis
Emerson's stock is in a clear uptrend, with a 1-year price change of +20.89% and a current price of $157.26, which is near the upper end of its 52-week range (52-week low: $122.64, high: $166.35). The stock is trading at approximately 94.5% of its 52-week range, indicating strong momentum and investor confidence, though it also suggests the stock may be approaching overbought conditions. The 6-month price change of +5.81% is positive but lags the 1-year performance, suggesting the uptrend has been more pronounced over the longer term.
Beta
1.24
1.24x market volatility
Max Drawdown
-23.7%
Largest decline past year
52-Week Range
$123-$166
Price range past year
Annual Return
+20.9%
Cumulative gain past year
| Period | EMR Return | S&P 500 |
|---|---|---|
| 1m | +12.6% | +3.6% |
| 3m | +15.3% | +2.7% |
| 6m | +5.8% | +11.4% |
| 1y | +20.9% | +18.7% |
| ytd | +15.8% | +12.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
EMR Fundamental Analysis
Emerson's revenue growth has been steady but modest, with the most recent quarter (Q2 FY2026, ending March 31, 2026) reporting revenue of $4.562 billion, a 2.93% year-over-year increase. This growth is consistent with the prior quarter's revenue of $4.346 billion, indicating a stable, low-single-digit growth trajectory. The company's revenue segments show Intelligent Devices as the largest contributor at $2.512 billion, followed by Software and Systems at $1.503 billion, and Safety and Productivity at $0.547 billion, with the software segment likely driving higher-margin growth. The modest growth reflects the mature nature of the industrial automation market, but Emerson's focus on software and digital solutions may provide a catalyst for acceleration.
Quarterly Revenue
$4.6B
2026-03
Revenue YoY Growth
+2.9%
YoY Comparison
Gross Margin
53.1%
Latest Quarter
Free Cash Flow
$3.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is EMR Overvalued?
Given Emerson's positive net income, the PE ratio is the appropriate primary valuation metric. The trailing PE is 32.23x, while the forward PE is 21.74x, implying that the market expects significant earnings growth over the next year. This forward discount is substantial, suggesting that analysts anticipate a strong earnings rebound, possibly driven by margin expansion and cost synergies from recent acquisitions. The PEG ratio of 1.78x indicates that the stock is not excessively expensive relative to its expected growth, but it is not a deep value either.
PE
32.2x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 16x~47x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks: Emerson carries a moderate debt load with a debt-to-equity ratio of 0.68, which is manageable but not negligible. The current ratio of 0.88 indicates potential liquidity pressure, as current liabilities exceed current assets. However, strong free cash flow of $3.115 billion provides a cushion. The company's revenue growth is modest at 2.9% YoY, and any slowdown in industrial spending could pressure earnings. Additionally, the payout ratio of 52% leaves limited room for dividend increases if cash flow declines.
FAQ
The key risks include: 1) Financial risk: moderate debt levels (D/E of 0.68) and a current ratio below 1 could strain liquidity if cash flow declines. 2) Market risk: the stock is trading at a premium valuation, and any disappointment could lead to a de-rating. 3) Competitive risk: intense competition from larger players like Siemens and ABB could pressure margins. 4) Macro risk: with a beta of 1.235, the stock is sensitive to economic cycles, and a downturn could significantly impact earnings. The most severe risk is a global recession, which could push the stock to the low target of $104.
The 12-month forecast for EMR is moderately bullish. The base case, with a 50% probability, targets a range of $160-$180, aligning with the average analyst target of $171.07. The bull case, with a 25% probability, targets $180-$205, driven by accelerated growth and margin expansion. The bear case, also with a 25% probability, targets $104-$130, reflecting a potential downturn. The most likely scenario is the base case, where the stock continues to deliver steady growth and trades near the average target.
EMR is fairly valued relative to its growth prospects. The trailing PE of 32.2x is above the industrial sector average, but the forward PE of 21.7x suggests the market expects significant earnings growth. The PEG ratio of 1.78 indicates the stock is not excessively expensive. Compared to its own history, the stock is trading near the upper end of its valuation range, reflecting optimism about its strategic direction. The market is pricing in steady growth and margin expansion, which seems reasonable given the company's execution.
EMR is a good stock to buy for investors seeking a balanced risk/reward profile. The analyst consensus is 'Buy' with an average target price of $171.07, implying an 8.8% upside from the current price of $157.26. The stock offers a dividend yield of 1.61% and has shown strong momentum, up 20.9% over the past year. However, the valuation is not cheap, with a trailing PE of 32.2x, and the low analyst target of $104.00 highlights downside risk. It is a good buy for long-term investors who believe in the automation trend and can tolerate short-term volatility.
EMR is more suitable for long-term investment. The company is a leader in industrial automation, a secular growth trend, and has a solid track record of margin expansion and cash flow generation. The stock's beta of 1.235 indicates moderate volatility, making it less ideal for short-term trading. The dividend yield of 1.61% provides income, and the payout ratio of 52% suggests sustainability. A suggested minimum holding period is 3-5 years to fully benefit from the automation trend and the company's strategic initiatives.
